222 related articles for article (PubMed ID: 1699349)
1. Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus.
Rasmussen L; Battles JK; Ennis WH; Nagashima K; Gonda MA
Virology; 1990 Oct; 178(2):435-51. PubMed ID: 1699349
[TBL] [Abstract][Full Text] [Related]
2. Immunological characterization of the gag gene products of bovine immunodeficiency virus.
Battles JK; Hu MY; Rasmussen L; Tobin GJ; Gonda MA
J Virol; 1992 Dec; 66(12):6868-77. PubMed ID: 1331499
[TBL] [Abstract][Full Text] [Related]
3. Expression of bovine immunodeficiency-like virus envelope glycoproteins by a recombinant baculovirus in insect cells.
Rasmussen L; Greenwood JD; Gonda MA
Virology; 1992 Feb; 186(2):551-61. PubMed ID: 1310184
[TBL] [Abstract][Full Text] [Related]
4. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
[TBL] [Abstract][Full Text] [Related]
5. Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells.
Luo L; Li Y; Kang CY
Virology; 1990 Dec; 179(2):874-80. PubMed ID: 2238477
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of HTLV-II particle formation by recombinant baculovirus system].
Takahashi R
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):451-61. PubMed ID: 9846275
[TBL] [Abstract][Full Text] [Related]
7. Expression of feline leukaemia virus gp85 and gag proteins and assembly into virus-like particles using the baculovirus expression vector system.
Thomsen DR; Meyer AL; Post LE
J Gen Virol; 1992 Jul; 73 ( Pt 7)():1819-24. PubMed ID: 1321215
[TBL] [Abstract][Full Text] [Related]
8. Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus gag using baculovirus vectors.
Morikawa S; Booth TF; Bishop DH
Virology; 1991 Jul; 183(1):288-97. PubMed ID: 1647071
[TBL] [Abstract][Full Text] [Related]
9. In vitro detection of bovine immunodeficiency-like virus using monoclonal antibodies generated to a recombinant gag fusion protein.
Wannemuehler Y; Isaacson J; Wannemuehler M; Wood C; Roth JA; Carpenter S
J Virol Methods; 1993 Sep; 44(1):117-127. PubMed ID: 7693743
[TBL] [Abstract][Full Text] [Related]
10. Use of bacterial trpE fusion vectors to express and characterize the bovine immunodeficiency-like virus core protein.
Atkinson B; Liu ZQ; Wood C
J Virol Methods; 1992 Jan; 36(1):35-49. PubMed ID: 1372612
[TBL] [Abstract][Full Text] [Related]
11. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
Luo L; Li Y; Cannon PM; Kim S; Kang CY
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241
[TBL] [Abstract][Full Text] [Related]
12. Production of GP64-free virus-like particles from baculovirus-infected insect cells.
Chaves LCS; Ribeiro BM; Blissard GW
J Gen Virol; 2018 Feb; 99(2):265-274. PubMed ID: 29300162
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of monocyte migration and phagocytosis by the bovine immunodeficiency-like virus Gag proteins.
Rovid AH; Roth JA
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):18-25. PubMed ID: 8989206
[TBL] [Abstract][Full Text] [Related]
14. Development of a Western blot assay for detection of bovine immunodeficiency-like virus using capsid and transmembrane envelope proteins expressed from recombinant baculovirus.
Abed Y; St-Laurent G; Zhang H; Jacobs RM; Archambault D
Clin Diagn Lab Immunol; 1999 Mar; 6(2):168-72. PubMed ID: 10066648
[TBL] [Abstract][Full Text] [Related]
15. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells.
Bouamr F; Garnier L; Rayne F; Verna A; Rebeyrotte N; Cerutti M; Mamoun RZ
Virology; 2000 Dec; 278(2):597-609. PubMed ID: 11118382
[TBL] [Abstract][Full Text] [Related]
16. Loss of Gag-specific antibody reactivity in cattle experimentally infected with bovine immunodeficiency-like virus.
Isaacson JA; Roth JA; Wood C; Carpenter S
Viral Immunol; 1995; 8(1):27-36. PubMed ID: 8546802
[TBL] [Abstract][Full Text] [Related]
17. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
Tobin GJ; Li GH; Fong SE; Nagashima K; Gonda MA
Virology; 1997 Sep; 236(2):307-15. PubMed ID: 9325238
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the bovine immunodeficiency virus gag gene and development of a recombinant-protein-based enzyme-linked immunosorbent assay.
Zheng L; Swanson M; Liao J; Wood C; Kapil S; Snider R; Loughin TA; Minocha HC
Clin Diagn Lab Immunol; 2000 Jul; 7(4):557-62. PubMed ID: 10882651
[TBL] [Abstract][Full Text] [Related]
19. Characterization of bovine immunodeficiency virus rev cDNAs and identification and subcellular localization of the Rev protein.
Oberste MS; Williamson JC; Greenwood JD; Nagashima K; Copeland TD; Gonda MA
J Virol; 1993 Nov; 67(11):6395-405. PubMed ID: 8411341
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of contaminating RNA activity in HIV-1 Gag VLPs.
Valley-Omar Z; Meyers AE; Shephard EG; Williamson AL; Rybicki EP
Virol J; 2011 Oct; 8():462. PubMed ID: 21975161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]